227 related articles for article (PubMed ID: 4801225)
21. Influence of selected antiarrhythmic drugs on the hemodynamic parameters in rabbits during anesthesia. Part III. Ketamine anesthesia.
Orszulak-Michalak D
Pol J Pharmacol; 1995; 47(5):407-16. PubMed ID: 8868132
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacology of N-propyl-ajmaline bromide (NPAB)].
Gendenshteĭn EI
Farmakol Toksikol; 1970; 33(3):303-5. PubMed ID: 5453025
[No Abstract] [Full Text] [Related]
23. Hemodynamic effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) at rest and during exercise with special respect to the pulmonary circulation.
Koch G
Arzneimittelforschung; 1971 Jan; 21(1):57-61. PubMed ID: 5108382
[No Abstract] [Full Text] [Related]
24. [Quantitative comparative studies on the changing of the ventricular fibrillation threshold by antifibrillatory substances].
Diederich KW; Beeck J
Z Kreislaufforsch; 1970 Aug; 59(8):736-43. PubMed ID: 5513293
[No Abstract] [Full Text] [Related]
25. The influence of selected antiarrhythmic drugs on the hemodynamic parameters in rabbits during anesthesia. Part I. Propofol anesthesia.
Orszulak-Michalak D
Pol J Pharmacol; 1995; 47(2):143-52. PubMed ID: 8688887
[TBL] [Abstract][Full Text] [Related]
26. [Cardiovascular effects of glycerol-1-(2-diethyl-amino-ethylether)-3-(2-methoxyphenylether) in the anaesthetized cat (author's transl)].
Djonlagić H; Bauch W; Diederich KW
Arzneimittelforschung; 1975 Nov; 25(11):1776-80. PubMed ID: 1243086
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular effects of an antiarrhythmic aminosteroid ORG 6001 in the anesthetized pig.
Verdouw PD; Remme WJ; Beaune J; Rutteman AM; Hagemeijer F
Arzneimittelforschung; 1976; 26(8):1558-61. PubMed ID: 1036951
[TBL] [Abstract][Full Text] [Related]
28. [Toxic and hemodynamic effects of aprindine in the dog. Comparison with other anti-arrhythmia agents].
Lisin N; Carlier J
Acta Cardiol; 1974; Suppl 18():117-30. PubMed ID: 4547497
[No Abstract] [Full Text] [Related]
29. Cardiopulmonary effects of antimalarial drugs. VI. Adenosine, quinacrine and primaquine.
Bass SW; Ramirez MA; Aviado DM
Toxicol Appl Pharmacol; 1972 Apr; 21(4):464-81. PubMed ID: 5047047
[No Abstract] [Full Text] [Related]
30. Hemodynamic effects of isoproterenol in cardiac surgery.
Beregovich J; Reicher-Reiss H; Kunstadt D; Grishman A
J Thorac Cardiovasc Surg; 1971 Dec; 62(6):957-64. PubMed ID: 5129399
[No Abstract] [Full Text] [Related]
31. Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular function.
Tuininga YS; Crijns HJ; Oosterhuis B; Wiesfeld AC; van Wijk LM; Albronda F; de Bruin H; Jonkman JH; Kozma C; Lie KI
J Cardiovasc Pharmacol; 1994 Mar; 23(3):408-14. PubMed ID: 7515984
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamic effects of nitroglycerin and amyl nitrite in the conscious dog.
O'Rourke RA; Bishop VS; Kot PA; Fernandez JP
J Pharmacol Exp Ther; 1971 May; 177(2):426-32. PubMed ID: 4998697
[No Abstract] [Full Text] [Related]
33. [Combinations of anti-arrhythmia agents and the heart conduction system].
Pleskot M; Tilser P; Pidrman V
Vnitr Lek; 1988 Jan; 34(1):23-30. PubMed ID: 3354214
[No Abstract] [Full Text] [Related]
34. Pentazocine: hemodynamic and electrophysiologic properties.
Hayakawa H; Mandel WJ; Vyden JK; Parmley WW; Corday E; McCullen A; Allen D
J Clin Pharmacol; 1973; 13(8):313-24. PubMed ID: 4490007
[No Abstract] [Full Text] [Related]
35. Cardiovascular effects and blood concentrations of ajmaline and its 17-monochloroacetate ester in cats.
Spilker B; Shargel L; Koss RF; Minatoya H
Arch Int Pharmacodyn Ther; 1975 Jul; 216(1):63-78. PubMed ID: 1164107
[TBL] [Abstract][Full Text] [Related]
36. [Experimental study of the use of magnesium and of ajmaline in ventricular bathmotropic disorders secondary to acute coronary occlusion].
Critelli G; Cernigliaro C; Rizzo S; Santucci A; Marigliano V; Giuliano G
Atti Soc Ital Cardiol; 1969 Jan; 2():270-81. PubMed ID: 5406542
[No Abstract] [Full Text] [Related]
37. [Polygraphic study of the effects on myocardial contractility of a new anti-arrhythmic drug: N-propyl-ajmaline bitartrate].
De Luca I; Cristallo E; Landriscina B; Gianfrate P; Albanese P; Bacca F
Boll Soc Ital Cardiol; 1975; 20(4):335-41. PubMed ID: 1231913
[No Abstract] [Full Text] [Related]
38. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
Bergey JL; Sulkowski T; Much DR; Wendt RL
Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of ethanol in patients with cardiac disease.
Gould L; Zahir M; DeMartino A; Gomprecht RF; Jaynal F
Q J Stud Alcohol; 1972 Sep; 33(3):714-21. PubMed ID: 5076878
[No Abstract] [Full Text] [Related]
40. Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
Hansing CE; Folts JD; Afonso S; Rowe GG
J Pharmacol Exp Ther; 1972 Jun; 181(3):498-511. PubMed ID: 5033015
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
